Literature DB >> 25569738

Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.

Mike van der Have1, Herma H Fidder, Max Leenders, Ad A Kaptein, Mirthe E van der Valk, Ad A van Bodegraven, Gerard Dijkstra, Dirk J de Jong, Marieke Pierik, Cyriel Y Ponsioen, Andrea E van der Meulen-de Jong, C Janneke van der Woude, Paul C van de Meeberg, Mariëlle J L Romberg-Camps, Cees H M Clemens, Jeroen M Jansen, Nofel Mahmmod, Clemens J M Bolwerk, J Reinoud Vermeijden, Peter D Siersema, Bas Oldenburg.   

Abstract

BACKGROUND: The inflammatory bowel disease (IBD) disability index has recently been introduced to measure patients' physical, psychological, familial, and social limitations associated with IBD. We assessed factors related to self-reported disability and the relationship between disability and direct health care costs.
METHODS: A large cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC) was prospectively followed for 2 years by 3 monthly web-based questionnaires. At 2 years, patients completed the IBD disability index, with lower score indicating more disability. Linear regression analysis was used to examine the impact of demographics, clinical characteristics, and illness perceptions on self-reported disability. Trends in direct health care costs across the disability severity groups minimal, mild, moderate, and severe, were tested.
RESULTS: A total of 554 patients with CD and 424 patients with UC completed the IBD disability index (response rate, 45%). Both clinical characteristics and illness perceptions significantly contributed to self-reported disability (45%-47%, P = 0.000 and 8%-12%, P = 0.000, respectively). Patients with CD scored lower on the self-reported IBD disability index than patients with UC (0.255 versus 3.890, P < 0.000), indicating more disability in patients with CD. Factors independently associated with higher self-reported disability rates were increased disease activity, illness identity (higher number of symptoms attributed to IBD), and stronger emotional response. Disease duration and disease phenotype were not associated with self-reported disability. Direct health care costs increased with the worsening of self-reported disability (P = 0.000).
CONCLUSIONS: More disability was reported by patients with CD than by UC. Self-reported disability in IBD was mainly determined by clinical disease activity and illness perceptions but not by disease duration or disease phenotype.

Entities:  

Mesh:

Year:  2015        PMID: 25569738     DOI: 10.1097/MIB.0000000000000278

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  16 in total

1.  Inflammatory bowel disease: Appreciating disability and impact of disease.

Authors:  Subrata Ghosh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

2.  Considering the Bidirectional Pathways Between Depression and IBD: Recommendations for Comprehensive IBD Care.

Authors:  Laurie Keefer; Sunanda V Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-03

3.  Examining Psychosocial Mechanisms of Pain-Related Disability in Inflammatory Bowel Disease.

Authors:  Katherine M Fretz; Dean A Tripp; Laura Katz; Mark Ropeleski; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2020-03

4.  Illness Perceptions and Outcomes in Patients with Inflammatory Bowel Disease: Is Coping a Mediator?

Authors:  S J H van Erp; L K M P Brakenhoff; M Vollmann; D van der Heijde; R A Veenendaal; H H Fidder; D W Hommes; A A Kaptein; Andrea E van der Meulen-de Jong; M Scharloo
Journal:  Int J Behav Med       Date:  2017-04

5.  Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.

Authors:  Dawn Farrell; Geraldine McCarthy; Eileen Savage
Journal:  J Crohns Colitis       Date:  2015-11-22       Impact factor: 9.071

Review 6.  Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.

Authors:  Muhammad Sohail; Muhammad Usman Minhas; Shahzeb Khan; Zahid Hussain; Marcel de Matas; Syed Ahmed Shah; Samiullah Khan; Mubeen Kousar; Kaleem Ullah
Journal:  Drug Deliv Transl Res       Date:  2019-04       Impact factor: 4.617

7.  Body Mass Index and Disease Activity Are Associated With Moderate to Severe Disability in Crohn's Disease: A Cross-Sectional Study in Shanghai.

Authors:  DongSheng Bian; Yongmei Jiang; Yubei Gu; Zirui He; Qi Chen; Yonghua Tang; Jie Zhong; Yongmei Shi
Journal:  Front Med (Lausanne)       Date:  2021-07-09

Review 8.  Care of inflammatory bowel disease patients in remission.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-10

9.  The clinical usefulness of a web-based messaging system between patients with Crohn disease and their physicians.

Authors:  Da Eun Jeong; Kyeong Ok Kim; Byung Ik Jang; Eun Young Kim; Jin Tae Jung; Seong Woo Jeon; Hyun Seok Lee; Eun Soo Kim; Kyung Sik Park; Kwang Bum Cho
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Good Psychometric Properties of the Addiction Version of the Revised Illness Perception Questionnaire for Health Care Professionals.

Authors:  Astri Parawita Ayu; Boukje Dijkstra; Milou Golbach; Cor De Jong; Arnt Schellekens
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.